Crossprotection induced by virus-like particles containing influenza dual-hemagglutinin and M2 ectodomain

被引:0
|
作者
Mao, Jie [1 ]
Eom, Gi-Deok [1 ]
Yoon, Keon-Woong [1 ]
Kim, Min-Ju [1 ]
Chu, Ki-Back [2 ]
Kang, Hae-Ji [3 ]
Quan, Fu-Shi [2 ,4 ]
机构
[1] Kyung Hee Univ, Grad Sch, Dept Biomed Sci, Seoul 02447, South Korea
[2] Kyung Hee Univ, Biomed Sci Inst, Core Res Inst CRI, Med Res Ctr Bioreact React Oxygen Species, Seoul 02447, South Korea
[3] Georgia State Univ, Inst Biomed Sci, Ctr Translat Antiviral Res, Atlanta, GA 30303 USA
[4] Kyung Hee Univ, Sch Med, Dept Med Zool, Seoul 02447, South Korea
基金
新加坡国家研究基金会;
关键词
hemagglutinin; influenza virus; M2e5x; universal vaccine; virus-like particles; CROSS-PROTECTION; VACCINE; MICE; H1N1; INFECTION; IMMUNITY; SUBTYPES;
D O I
10.2217/nnm-2023-0353
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Aims: To develop an effective universal vaccine against antigenically different influenza viruses. Materials & methods: We generated influenza virus-like particles (VLPs) expressing the H1 and H3 antigens with or without M2e5x. VLP-induced immune responses and crossprotection against H1N1, H3N2 or H5N1 viruses were assessed to evaluate their protective efficacy. Results: H1H3M2e5x immunization elicited higher crossreactive IgG antibodies than H1H3 VLPs. Upon challenge, both VLPs enhanced lung IgG, IgA and germinal center B-cell responses compared with control. While these VLPs conferred protection, H1H3M2e5x showed greater lung viral load reduction than H1H3 VLPs with minimal body weight loss. Conclusion: Utilizing VLPs containing dual-hemagglutinin, along with M2e5x, can be a vaccination strategy for inducing crossprotection against influenza A viruses. [GRAPHICS] .
引用
收藏
页码:741 / 754
页数:14
相关论文
共 50 条
  • [21] Chimeric Virus-like Particles of Physalis Mottle Virus as Carriers of M2e Peptides of Influenza a Virus
    Blokhina, Elena A.
    Mardanova, Eugenia S.
    Zykova, Anna A.
    Shuklina, Marina A.
    Stepanova, Liudmila A.
    Tsybalova, Liudmila M.
    Ravin, Nikolai V.
    VIRUSES-BASEL, 2024, 16 (11):
  • [22] Vaccine efficacy induced by 2020-2021 seasonal influenza-derived H3N1 virus-like particles co-expressing M2e5x or N2
    Mao, Jie
    Kang, Hae-Ji
    Eom, Gi-Deok
    Yoon, Keon-Woong
    Chu, Ki Back
    Quan, Fu-Shi
    VACCINE, 2025, 43
  • [23] Protection induced by early stage vaccination with pandemic influenza virus-like particles
    Lee, Gi-Ja
    Quan, Fu-Shi
    VACCINE, 2016, 34 (33) : 3764 - 3772
  • [24] Dual display hemagglutinin 1 and 5 on the surface of enveloped virus-like particles in silkworm expression system
    Goffar, Muzajjad Gozal
    Deo, Vipin Kumar
    Kato, Tatsuya
    Park, Enoch Y.
    PROTEIN EXPRESSION AND PURIFICATION, 2022, 197
  • [25] Intranasally administered polyethylenimine adjuvanted influenza M2 ectodomain induces partial protection against H9N2 influenza A virus infection in chickens
    Hajam, Irshad Ahmed
    Kim, Jehyoung
    Lee, John Hwa
    VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY, 2019, 209 : 78 - 83
  • [26] Development and characterization of influenza M2 ectodomain and/or hemagglutinin stalk-based dendritic cell-targeting vaccines
    Olukitibi, Titus Abiola
    Ao, Zhujun
    Azizi, Hiva
    Mahmoudi, Mona
    Coombs, Kevin
    Kobasa, Darwyn
    Kobinger, Gary
    Yao, Xiaojian
    FRONTIERS IN MICROBIOLOGY, 2022, 13
  • [27] SARS-CoV-2 spike-based virus-like particles incorporate influenza H1/N1 antigens and induce dual immunity in mice
    Sanchez-Martinez, Zalma V.
    Alpuche-Lazcano, Sergio P.
    Stuible, Matthew
    Akache, Bassel
    Renner, Tyler M.
    Deschatelets, Lise
    Dudani, Renu
    Harrison, Blair A.
    Mccluskie, Michael J.
    Hrapovic, Sabahudin
    Blouin, Julie
    Wang, Xinyu
    Schuller, Matthew
    Cui, Kai
    Cho, Jae-Young
    Durocher, Yves
    VACCINE, 2024, 42 (26)
  • [28] Protective Immunity Induced by Incorporating Multiple Antigenic Proteins of Toxoplasma gondii Into Influenza Virus-Like Particles
    Lee, Su-Hwa
    Kang, Hae-Ji
    Lee, Dong-Hun
    Quan, Fu-Shi
    FRONTIERS IN IMMUNOLOGY, 2019, 9
  • [29] Acylation and cholesterol binding are not required for targeting of influenza A virus M2 protein to the hemagglutinin-defined budozone
    Thaa, Bastian
    Siche, Stefanie
    Herrmann, Andreas
    Veit, Michael
    FEBS LETTERS, 2014, 588 (06) : 1031 - 1036
  • [30] Improving Cross-Protection against Influenza Virus Using Recombinant Vaccinia Vaccine Expressing NP and M2 Ectodomain Tandem Repeats
    Wang, Wenling
    Huang, Baoying
    Wang, Xiuping
    Tan, Wenjie
    Ruan, Li
    VIROLOGICA SINICA, 2019, 34 (05) : 583 - 591